Hide Board Information

Show Board Information

PharmaCyte Biotech Inc. PMCB

Board Mod: Add me as mod

Asst Mods:

Last Post: 11/15/2023 8:10:49 AM

Board Marks: 56

Posts Today: 0

Board Views Today: 139

PharmaCyte Biotech Inc. (NASDAQ: PMCB) Stock Message Board

1. PMCB Company Profile

    

2. PMCB Time & Sales

    

3. PMCB Recent News

    

4. PMCB Filings

    

5. PMCB Financials

    

6. PMCB Buy Rating

Create New Post View All Posts Board Mark Banned

Post

Subject

Author

Posted On

295	$NVLX Inno Biologics Begins Cell Cloning	stocklegend	01/29/2014 3:58:37 PM
294	$NVLX Nuvilex Announces Cloning of Cells for	stocklegend	01/29/2014 2:11:23 PM
293	$NVLX Nuvilex Completes Acquisition of	stocklegend	01/29/2014 2:01:12 PM
292	$NVLX Nuvilex Accelerates Development of	stocklegend	01/29/2014 1:46:28 PM
291	$NVLX Nuvilex's Acquisition of Diabetes	stocklegend	01/29/2014 1:13:59 PM
290	$NVLX Nuvilex Ahead of the Curve on	stocklegend	01/29/2014 12:51:13 PM
289	$NVLX Investors Confidently Back Nuvilex's	stocklegend	01/29/2014 11:56:37 AM
288	$NVLX Diabetes Treatment Drives Big Increase	stocklegend	01/29/2014 11:36:42 AM
287	$NVLX After Pancreatic Cancer, Eli Lilly and	stocklegend	01/29/2014 10:37:17 AM
286	$NVLX Nuvilex and Eli Lilly Going Head to	stocklegend	01/29/2014 10:01:23 AM
285	$NVLX Nuvilex Appoints Dr. Mark Rabe, a	stocklegend	01/29/2014 9:37:53 AM
284	$NVLX Nuvilex Begins Making Moves at its	stocklegend	01/29/2014 9:14:26 AM
283	$NVLX Nuvilex's Medical Marijuana Subsidiary	stocklegend	01/29/2014 8:46:56 AM
282	$NVLX Nuvilex COO, Dr. Gerald Crabtree,	stocklegend	01/28/2014 3:39:00 PM
281	$NVLX Nuvilex COO Talks About Companys	stocklegend	01/28/2014 3:20:27 PM
280	$NVLX Nuvilex, Inc. Featured on Forbes:	stocklegend	01/28/2014 2:22:54 PM
279	$NVLX Nuvilex Listed in Forbes Article on	stocklegend	01/28/2014 1:38:34 PM
278	$NVLX - Nuvilex COO Talks Medical Marijuana in NY	stocklegend	01/28/2014 12:15:23 PM
277	$NVLX - Nuvilex Featured in Forbes and NY Post	stocklegend	01/28/2014 11:36:48 AM
276	$NVLX - Nuvilex Acquires Cancer Cell	stocklegend	01/28/2014 11:05:41 AM
275	$NVLX - Nuvilex Acquires Cancer Technology, Next	stocklegend	01/28/2014 10:19:28 AM
274	$NVLX - Nuvilex Restructures its Operations to	stocklegend	01/28/2014 9:58:22 AM
273	$NVLX - Nuvilex Restructures to Focus on	stocklegend	01/28/2014 9:32:56 AM
272	$NVLX - Nuvilex Enters Most Important Step of	stocklegend	01/28/2014 9:17:32 AM
271	$NVLX - Nuvilex Enters Most Important Step of	stocklegend	01/28/2014 8:49:13 AM
270	$NVLX Nuvilex, Inc. Featured on Forbes:	stocklegend	01/27/2014 3:42:16 PM
269	$NVLX Nuvilex COO Talks About Companys	stocklegend	01/27/2014 3:20:19 PM
268	$NVLX Nuvilex COO, Dr. Gerald Crabtree,	stocklegend	01/27/2014 3:06:46 PM
267	$NVLX Inno Biologics Begins Cell Cloning	stocklegend	01/27/2014 2:40:30 PM
266	$NVLX Nuvilex Announces Cloning of Cells for	stocklegend	01/27/2014 2:18:40 PM
265	$NVLX Nuvilex Completes Acquisition of	stocklegend	01/27/2014 2:18:27 PM
264	$NVLX Nuvilex Accelerates Development of	stocklegend	01/27/2014 1:21:09 PM
263	$NVLX Nuvilex's Acquisition of Diabetes	stocklegend	01/27/2014 12:56:23 PM
262	$NVLX Nuvilex Ahead of the Curve on	stocklegend	01/27/2014 12:39:03 PM
261	$NVLX Investors Confidently Back Nuvilex's	stocklegend	01/27/2014 12:14:16 PM
260	$NVLX Diabetes Treatment Drives Big Increase	stocklegend	01/27/2014 11:47:21 AM
259	$NVLX After Pancreatic Cancer, Eli Lilly and	stocklegend	01/27/2014 11:07:24 AM
258	NVLX NEWS:	stocklegend	01/27/2014 10:27:33 AM
257	$NVLX Nuvilex and Eli Lilly Going Head to	stocklegend	01/27/2014 9:40:44 AM
256	$NVLX Nuvilex Appoints Dr. Mark Rabe, a	stocklegend	01/27/2014 9:33:37 AM
255	$NVLX Nuvilex Begins Making Moves at its	stocklegend	01/27/2014 9:07:22 AM
254	$NVLX Nuvilex's Medical Marijuana Subsidiary	stocklegend	01/27/2014 8:49:13 AM
253	$NVLX breakout candles called $0.15 PYCKtradr	PoemStone	01/27/2014 7:48:33 AM
252	$NVLX - Nuvilex Featured in Forbes and NY Post	stocklegend	01/24/2014 11:52:22 AM
251	$NVLX - Nuvilex Acquires Cancer Cell	stocklegend	01/24/2014 11:48:44 AM
250	$NVLX - Nuvilex Acquires Cancer Technology, Next	stocklegend	01/24/2014 10:19:25 AM
249	$NVLX - Nuvilex Restructures its Operations to	stocklegend	01/24/2014 9:53:57 AM
248	NVLX news:	stocklegend	01/24/2014 9:43:48 AM
247	$NVLX - Nuvilex Restructures to Focus on	stocklegend	01/24/2014 9:41:33 AM
246	$NVLX - Nuvilex Contracts with Inno Biologics to	stocklegend	01/24/2014 9:00:48 AM

Newer

Older

Recent Articles

• O2Gold Expands Acquisition Plans for Quebec Aur Property
• Brazil Potash Celebrates Successful Initial Public Offering
• ISS Endorses Director Nominees for Carver Bancorp, Inc.
• Deadline for Shareholder Distribution Approval Announced by LWP
• Axis Auto Finance Inc. Annual Meeting Voting Results Overview
• Fluent, Inc. Secures $5.75 Million Through Direct Offerings
• The Future of Silicon Photonics: Trends and Insights for Growth
• Expansion of Managed Services Market in Saudi Arabia Forecasted
• Cloud ERP Market Growth Driven by AI and Digital Transformation
• Exploring the Growth of the Titanium Market and AI's Impact
• Syntheia: Transforming Customer Engagement with AI Solutions
• Photonics Market Growth Forecast: Major Innovations Ahead
• Strategic Management Transition at Premier American Uranium
• Financial Overview of Patagonia Gold for Q3 2024
• First Savings Financial Group Declares Quarterly Dividend for 2024
• Anoto Group Introduces Its Latest Prospectus for Investment Opportunities
• Inovalis REIT Moves Forward with €18.2 Million Property Sale
• State Street Leadership Prepares for Goldman Sachs Conference
• XTM Inc. Celebrates Impressive Q3 2024 Performance with Growth
• Investors Excited for Lightspeed's Upcoming Conference Participation
• Emerging Trends in Cannabis Testing Market Boost Growth
• Halmont Properties' Strong Q3 Performance and Future Outlook
• Brookfield Infrastructure Announces Major Subordinated Note Deal
• Investigation Launched Against Customers Bancorp, Inc. Amid Losses
• Red White & Bloom Achieves Major Growth in Q3 Financials
• Cue Biopharma Welcomes New Chief Development Officer
• WeRide Inc. Launches GXR Robotaxi Platform and Strategic Growth
• Aspen Insurance's Preference Shares Redemption Announcement
• Chemours Successfully Reprices U.S. Dollar Term Loan Facility
• Understanding the Walgreens Boots Alliance Shareholder Settlement
• Innovative Mobile MRI Scanner Revolutionizes Healthcare Imaging
• Amgen Leadership Set to Speak at Key Healthcare Conference
• JB Perrette to Share Insights at Upcoming TMT Summit Event
• Neuberger Berman Real Estate Fund Declares Monthly Dividend
• Neuberger Berman Energy Fund Declares Monthly Cash Distribution
• Neuberger Berman Connectivity Fund Updates Share Distributions
• Neuberger Berman High Yield Strategies Fund Declares Monthly Payout
• Sirios Resources Plans Key Private Placements to Boost Growth
• TransCode Therapeutics Implements 1-for-33 Reverse Stock Split
• Aspen Insurance Announces Significant Preference Share Dividends
• PGIM High Yield Funds Announce Monthly Distributions
• iClick Interactive's Strategic Merger with Amber DWM Explained
• Reflecting on World AIDS Day: A Call to Action for Hope
• A21's Campaign Against Human Trafficking Hits New Heights
• Verve Therapeutics Expands Talent with New Stock Grants
• Globus Maritime Limited's Q3 2024 Financial Overview
• AI Transportation Acquisition Corp Shifts Focus After Agreement Ends
• ACM Research Engages Investors at the NYC Summit 2024 Event
• Triumph Financial Declares Dividend for Series C Preferred Stock
• Future Vision II and Viwo Technology Join Forces in Exciting Merger